Cerveau Technologies Inc. Signs Collaboration Agreement with Janssen for Novel Tau Imaging Agent
17 October 2017
Cerveau Technologies, Inc. today announced a research collaboration agreement with Janssen Pharmaceuticals, Inc. for use of [F-18]MK-6240, an investigational imaging agent to be used in Positron Em
